B
Brigitte Dupriez
Researcher at Lille University of Science and Technology
Publications - 63
Citations - 6243
Brigitte Dupriez is an academic researcher from Lille University of Science and Technology. The author has contributed to research in topics: Myelofibrosis & Transplantation. The author has an hindex of 31, co-authored 62 publications receiving 5781 citations.
Papers
More filters
Journal ArticleDOI
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment.
Francisco Cervantes,Brigitte Dupriez,Arturo Pereira,Francesco Passamonti,John T. Reilly,Enrica Morra,Alessandro M. Vannucchi,Ruben A. Mesa,Jean Loup Demory,Giovanni Barosi,Elisa Rumi,Ayalew Tefferi +11 more
TL;DR: In 409 patients with assessable metaphases, cytogenetic abnormalities were associated with shorter survival, but their independent contribution to prognosis was restricted to patients in the intermediate-risk groups.
Journal ArticleDOI
Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system [see comments]
Brigitte Dupriez,Pierre Morel,Jean-Loup Demory,Jean-Luc Laï,Marc A. Simon,Isabelle Plantier,Francis Bauters +6 more
TL;DR: Hemoglobin level and leukocyte count provide a simple prognostic model for survival in AMM, and the adverse prognostic value of abnormal karyotype may be related to a higher rate of acute conversion.
Journal ArticleDOI
Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system
Brigitte Dupriez,Pierre Morel,Jean Loup Demory,Jean L. Lai,Marc A. Simon,Isabelle Plantier,Francis Bauters +6 more
TL;DR: In this article, the authors studied the survival of 195 patients with agnogenic myeloid metaplasia (AMM) diagnosed between 1962 and 1992 in an attempt to stratify patients into risk groups.
Journal ArticleDOI
Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment.
Giovanni Barosi,Ruben A. Mesa,Juergen Thiele,Francisco Cervantes,Peter J. Campbell,Srdan Verstovsek,Brigitte Dupriez,Ross L. Levine,Francesco Passamonti,Jason Gotlib,John T. Reilly,Alessandro M. Vannucchi,C A Hanson,Lawrence A. Solberg,Attilio Orazi,Ayalew Tefferi +15 more
TL;DR: Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myel ofibrosis research and treatment.
Journal ArticleDOI
International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT).
Ayalew Tefferi,Giovanni Barosi,Ruben A. Mesa,Francisco Cervantes,H. Joachim Deeg,John T. Reilly,Srdan Verstovsek,Brigitte Dupriez,Richard T. Silver,Olatoyosi Odenike,Jorge E. Cortes,Martha Wadleigh,Lawrence A. Solberg,John K. Camoriano,Heinz Gisslinger,Pierre Noel,Juergen Thiele,James W. Vardiman,Ronald Hoffman,Nicholas C.P. Cross,D. Gary Gilliland,Hagop M. Kantarjian +21 more
TL;DR: An international panel of experts recently convened and delineated 3 response categories: complete remission (CR), partial remission (PR), and clinical improvement (CI).